Proteins that interact with the ER from outside all interact with VAP.
VAP has a conserved domain with multiple binding sites for different ligands.
≥ 50% of VAP binders have motifs in the general form of “two phenylalanines in an acidic tract” (FFAT).
Neurodegeneration is associated with reduced levels of VAP.
Many myths about VAP pathology result from experiments with over-expression.